President signs FDA Reauthorization Act

AHA News Now

President Trump Friday signed into law the FDA Reauthorization Act (H.R. 2430). The bill reauthorizes and amends four FDA user fee programs under which companies that develop drugs and medical devices partially pay for premarket review of their products. The bill also includes provisions intended to... read more

Topic: Advocacy and Public Policy
Tag: drug prices

CMS projects Part D monthly premium to decline slightly in 2018

AHA News Now

The average monthly premium for a basic Medicare Part D prescription drug plan in 2018 is estimated to be $33.50 per month – or approximately $1.20 less than the average premium in 2017 – the Centers for Medicare & Medicaid Services announced last week. The projection is based on bids submitted by drug... read more

Topic: Access and Coverage
Tag: drug prices

Senate passes FDA Reauthorization Act

AHA News Now

The Senate yesterday voted 94-1 to approve the FDA Reauthorization Act (H.R. 2430), sending the legislation to the president for his signature. The bill reauthorizes and amends four FDA user fee programs under which companies that develop drugs and medical devices partially pay for premarket review of... read more

Topic: Advocacy and Public Policy
Tags: regulation, opioids, drug prices

Democratic leaders unveil economic agenda

AHA News Now

Senate Democratic Leader Charles Schumer and House Democratic Leader Nancy Pelosi today unveiled an economic plan focused on improving wages, lowering costs and boosting job opportunities. To lower the cost of prescription drugs, the plan calls for creating a new agency to investigate and take action... read more

Topic: Advocacy and Public Policy
Tags: Medicare, drug prices

CMS releases 2018 OPPS/ASC proposed rule

AHA News Now

The Centers for Medicare & Medicaid Services today proposed to update hospital outpatient prospective payment system rates by 1.75% in calendar year 2018 compared to CY 2017. The rule also would drastically cut Medicare payment for drugs that are acquired under the 340B Drug Pricing Program. Specifically,... read more

Topic: Advocacy and Public Policy
Tags: 340B, quality, physicians, site neutral payment, Medicare, rural, Critical Access Hospitals, regulation, drug prices

MedPAC issues June report to Congress

AHA News Now

The Medicare Payment Advisory Commission yesterday released its June report to Congress, which includes the panel’s recent recommendations for reforming Medicare payment for Part B drugs and accelerating the roll out of a post-acute care prospective payment system. The report also discusses possible... read more

Topic: Advocacy and Public Policy
Tags: physicians, Medicare, rural, emergency care, drug prices

AHA urges Congress to address rising cost of drugs

AHA News Now

The AHA today urged Congress and the administration to take immediate action to rein in the rising cost of drugs. In a statement submitted to the Senate Committee on Health, Education, Labor and Pensions for a hearing on the issue, AHA offered specific recommendations to increase competition, innovation... read more

Topic: Advocacy and Public Policy
Tag: drug prices

Reining in drug prices

Blog

A Senate committee today shined the spotlight on the wave of high and unexpected increases in prescription drug costs that puts an incredible financial strain on hospitals and health systems and threaten our ability to provide high quality care each and every day.

In a statement submitted to the... read more

Topic: Advocacy and Public Policy
Tag: drug prices

HRSA delays until Oct. 1 the effective date of final rule on 340B drug ceiling prices

AHA News Now

The Health Resources and Services Administration today delayed to Oct. 1 the effective date of its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers. The final rule was subject to multiple delays since January. “The additional time provided to the public before the rule... read more

Topic: Advocacy and Public Policy
Tags: 340B, regulation, drug prices

Poll: Lowering prescription drug costs a high priority for many Americans

AHA News Now

Six in 10 Americans identify lowering the cost of prescription drugs as a “top priority” for President Trump and Congress when it comes to health care, according to a recent poll by the Kaiser Family Foundation. When asked about specific proposals to hold down drug costs, a majority of adults support... read more

Topic: Advocacy and Public Policy
Tags: Medicare, drug prices

Keyword Search

Date